Despite some variability due to methodological differences and limited statistical significance, the overall trend indicates that CCND1 upregulation may be linked to more aggressive tumor behavior in advanced endometrial cancer stages, warranting further investigation in larger, well-defined cohorts. The gene discussed is CCND1; the disease is neoplasm.